BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10500824)

  • 1. Activity of vinorelbine on B-chronic lymphocytic leukemia cells in vitro.
    Bernabei PA; Landini I; Bartolozzi B; Banchelli I; Degli Innocenti o Nocentini A; Santini V; Ematologia UO
    Adv Exp Med Biol; 1999; 457():473-6. PubMed ID: 10500824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of vinorelbine on human leukemia cells.
    Landini I; Bartolozzi B; Banchelli I; Degli Innocenti A; Nocentini O; Bernabei PA
    J Chemother; 2001 Jun; 13(3):309-15. PubMed ID: 11450890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
    Kanazawa J; Morimoto M; Ohmori K
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of vinorelbine in gastrointestinal cancers.
    Conroy T
    Crit Rev Oncol Hematol; 2002 May; 42(2):173-8. PubMed ID: 12007975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias.
    Uckun FM; Morar S; Qazi S
    Br J Haematol; 2006 Nov; 135(4):500-8. PubMed ID: 17061978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin attenuates vinorelbine-induced endothelial inflammation via modulating SIRT1/AMPK axis.
    Tsai KL; Huang PH; Kao CL; Leu HB; Cheng YH; Liao YW; Yang YP; Chien Y; Wang CY; Hsiao CY; Chiou SH; Chen JW; Lin SJ
    Biochem Pharmacol; 2014 Mar; 88(2):189-200. PubMed ID: 24345330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to vinorelbine inhibits in vitro proliferation and invasiveness of transitional cell bladder carcinoma.
    Bonfil RD; Russo DM; Schmilovich AJ
    J Urol; 1996 Aug; 156(2 Pt 1):517-21. PubMed ID: 8683728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells.
    Menéndez JA; Ropero S; del Barbacid MM; Montero S; Solanas M; Escrich E; Cortés-Funes H; Colomer R
    Breast Cancer Res Treat; 2002 Apr; 72(3):203-19. PubMed ID: 12058962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol protects against vinorelbine-induced vascular endothelial cell injury.
    Zhang J; Tong N; Chen Y; Li P; Yang S; Zhao X
    Toxicol Mech Methods; 2013 Nov; 23(9):665-71. PubMed ID: 23977833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Vinorelbine on cell growth and apoptosis induction in human osteosarcoma in vitro.
    Roncuzzi L; Marti G; Baiocchi D; Del Coco R; Cocchi S; Gasperi-Campani A
    Oncol Rep; 2006 Jan; 15(1):73-7. PubMed ID: 16328036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
    Ganeshaguru K; Wickremasinghe RG; Jones DT; Gordon M; Hart SM; Virchis AE; Prentice HG; Hoffbrand AV; Man A; Champain K; Csermak K; Mehta AB
    Haematologica; 2002 Feb; 87(2):167-76. PubMed ID: 11836167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with vinorelbine and other cytotoxic agents for advanced breast cancer patients--a protocol of vinorelbine plus AC regimens used by the Japan Vinorelbin Study Group].
    Saeki T; Adachi I; Ogita M; Tabei T; Shin E; Tamura K; Takashima S
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1180-4. PubMed ID: 10945014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells.
    Chiu WH; Su WC; Li CL; Chen CL; Lin CF
    Oncotarget; 2015 Aug; 6(24):20513-24. PubMed ID: 26001295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative genotoxic effect of vincristine, vinblastine, and vinorelbine in somatic cells of Drosophila melanogaster.
    Tiburi M; Reguly ML; Schwartsmann G; Cunha KS; Lehmann M; Rodrigues de Andrade HH
    Mutat Res; 2002 Aug; 519(1-2):141-9. PubMed ID: 12160899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro study on the effect of vinca alkaloid, vinorelbine, on chromatin histone, HMGB proteins and induction of apoptosis in mice non-adherent bone marrow cells.
    Rabbani-Chadegani A; Paydar P; Amirshenava M; Aramvash A
    Drug Chem Toxicol; 2015 Apr; 38(2):220-6. PubMed ID: 25004144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of vinorelbine in the cancer therapy.
    Galano G; Caputo M; Tecce MF; Capasso A
    Curr Drug Saf; 2011 Jul; 6(3):185-93. PubMed ID: 22122393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinorelbine-induced oxidative injury in human endothelial cells mediated by AMPK/PKC/NADPH/NF-κB pathways.
    Tsai KL; Chiu TH; Tsai MH; Chen HY; Ou HC
    Cell Biochem Biophys; 2012 Apr; 62(3):467-79. PubMed ID: 22194154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Taxol cytotoxicity on B-CLL cells in vitro.
    Di Raimondo F; Palumbo GA; Romeo MA; Galvagno F; Stagno F; Morabito F; Giustolisi R
    Leuk Lymphoma; 1997 Jun; 26(1-2):115-9. PubMed ID: 9250795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y.
    Bilir A; Erguven M; Yazihan N; Aktas E; Oktem G; Sabanci A
    J Neurooncol; 2010 Dec; 100(3):385-95. PubMed ID: 20467784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies.
    Izumi H; Touge H; Igishi T; Makino H; Nishii-Ito S; Takata M; Nakazaki H; Ueda Y; Matsumoto S; Kodani M; Kurai J; Takeda K; Sakamoto T; Yanai M; Tanaka N; Nirodi CS; Shimizu E
    Int J Oncol; 2015 Mar; 46(3):989-98. PubMed ID: 25573239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.